Professor, University of Wisconsin-Miwaukee, United States.
Dr. Avik Roy is the Chief Scientific Officer at Simmaron Research Institute and an Adjunct Professor at the University of Wisconsin-Milwaukee. With a PhD in Neuroscience from Rush University Medical Center, his research focuses on the role of nitric oxide and chronic inflammation in neurodegenerative diseases. He has contributed significantly to studies on Parkinson’s, ME/CFS, and Long-COVID, leading to innovative research on autophagy and neurodegeneration. His work has garnered numerous grants and awards, advancing understanding in both basic and clinical neurobiology. 🧠🔬💡
Profile:
Orcid
Scopus
Google Scholar
Education and Experience:
Dr. Avik Roy earned his M.S. in Biochemistry & Chemistry from the University of Calcutta and a PhD in Neuroscience from Rush University Medical Center. His research journey includes a postdoctoral fellowship in Neurological Sciences, followed by an Assistant Professorship at Rush University. Currently, he serves as Chief Scientific Officer at Simmaron Research and Adjunct Professor at UWM. His expertise spans biochemistry, neurodegenerative diseases, and chronic inflammation. 🏫🧬📚
Professional Development:
Dr. Roy’s professional development has been marked by his progression from a Research Fellow to an Assistant Professor and Chief Scientific Officer. His work in neuroinflammation, nitric oxide, and the pathogenesis of neurodegenerative diseases has been recognized globally. As a principal investigator, he leads various innovative projects, earning several research grants, including the NIH R21 and Ramsay Award. His involvement as a reviewer for key journals further highlights his academic leadership. 🌍🎓💼
Research Focus:
Dr. Avik Roy’s research focuses on understanding the molecular mechanisms driving neurodegenerative diseases such as Parkinson’s, ME/CFS, and Long-COVID. He investigates the role of nitric oxide, microglial activation, and inflammation in the degeneration of dopaminergic neurons. His pioneering work on autophagy, mTOR signaling, and chronic inflammation provides valuable insights into neurodegeneration and offers potential therapeutic strategies for these diseases. 🧠🧬🩺
Publications Cited By & Year:
- Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss (2007) 🧠📚
- Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease (2020) 🦠🧬
- Up-regulation of microglial CD11b expression by nitric oxide (2006) 💥🧠
- Simvastatin inhibits the activation of p21ras in Parkinson’s disease (2009) 💊🧠
- Regulation of CREB and hippocampal genes by PPARα (2013) 🧠🔬
- Cinnamon activates PPARα to lower Alzheimer’s plaque pathology (2019) 🍏🧠
- Up-regulation of neurotrophic factors by sodium benzoate in Alzheimer’s (2013) 🧪🧠
- Sodium phenylbutyrate protects dopaminergic neurons in Parkinson’s (2012) 💊🧠